Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

A woman with severe hair loss was successfully treated with the drug adalimumab.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.